“alexandria-venture-investments” Archives

in
Entry Author Date Location
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery 07/22/20 Boston
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Nitrome Bio Bags $38M to Prep Parkinson’s Program for the Clinic 04/23/20 San Francisco
Kallyope Gains $112M to Move “Gut-Brain Axis” Programs to the Clinic 03/25/20 New York
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy 01/08/20 San Francisco
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy 12/12/19 San Diego
Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs 11/13/19 San Diego
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer 10/21/19 Boston
Molecular Assemblies Raises $12M to Advance Enzymatic DNA Synthesis 10/01/19 San Diego
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M 09/19/19 San Diego
Boston Tech Watch: Cisco, Acacia, Great Hill Partners & GNS Healthcare 07/12/19 Boston
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? 06/13/19 San Francisco
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic 04/30/19 San Diego
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
Insitro Lands Three-Year Deal With Gilead to Find New NASH Drugs 04/16/19 National
San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More 04/11/19 San Diego
Seattle Startup Funding News: Immusoft, TurboPatent, VYRTY & More 01/04/19 Seattle
Tiburio Launches from Cydan with $31M to Tackle Pituitary Tumors 01/03/19 Boston
Relay Raises $400M to Kick Protein Motion Drug R&D into High Gear 12/20/18 Boston
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
OncoResponse Nabs $40M for Cancer Drugs Based On Survivors’ Antibodies 09/11/18 Texas
New Biotech Magnolia Neurosciences Gets $31M For Neuroprotective Drugs 08/13/18 New York
Inari Agriculture Harvests $40M to Ramp Up Gene Editing R&D 08/09/18 Boston
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Cibus Raises $70M for Marketing of Gene-Edited Canola, More R&D 06/27/18 San Diego
Don’t Be Boston 2.0, And Photos From “Bringing Back the Expats” 06/27/18 New York
Page 1 of 3 next page »